Of the genes previously reported to increase the risk for PrCa development (after excluding cases with known mutations in HOXB13, BRCA2 and MSH2 in this series), we found a nonsense mutation in ATM and a splicing mutation in CHEK2 (Table 1). This evidence concerns the gene BRCA2 and pure red-cell aplasia.